Bibliometric analysis of biomedical publications on SSRIs during 1980-2000

Depression and Anxiety

Volumn 18, Issue 2, 2003, Pages 95-103

  López Muñoz, Francisco ^a   Alamo, Cecilio ^a   Rubio, Gabriel ^b   García García, Pilar ^a   Martín Agueda, Belén ^a   Cuenca, Eduardo ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b NONE

Author keywords

Antidepressants; Anxiolytics; Bibliometry; SSRIs

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; EMBASE; HUMAN; MEDICAL LITERATURE; MEDLINE; OBSESSIVE COMPULSIVE DISORDER; PANIC; PHARMACOLOGY; PRIORITY JOURNAL; PRODUCTIVITY; PUBLICATION; UNITED STATES;

ANXIETY; BIBLIOMETRICS; DATABASES; DEPRESSIVE DISORDER; EFFICIENCY, ORGANIZATIONAL; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; PSYCHIATRY; PSYCHOPHARMACOLOGY; PUBLISHING; SEROTONIN UPTAKE INHIBITORS;

EID: 0141508009     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.10121     Document Type: Article

References (23)

1. Alamo C, López Muñoz F, Echániz T, Rubio G. 1996a. Bibliometric analysis on the SSRI for the period 1980-1994. In: X World Congress of Psychiatry, August 23-28, Madrid. Meeting book. p 288.
2. Alamo C, López-Muñoz F, Echániz T, Rubio G. 1996b. SSRI clinical use through the scientific publications. In: X World Congress of Psychiatry, August 23-28, Madrid. Meeting book. p 314.
3. Alamo C, López-Muñoz F, Cuenca E. 1998. Nuove prospettive terapeuiche degli SSRI. Psichiatria & Medicina II, 1, 2.
4. Bradford SC. 1948. Documentation. London: Crosby Lockwood.
5. Cuenca E, Alamo C, López-Muñoz F. 2002. Tratamiento en las neurosis. Psicofarmacología. In: Roca M, editor. Trastornos neuróticos. Barcelona: Ars Medica. p 823-866.
6. De Vane CL. 1994. Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 97(Suppl.):13-23.
7. Den Boer JA. 1998. Pharmacotherapy of panic disorder: Differential efficacy from a clinical viewpoint. J Clin Psychiatry 59:30-36.
8. Ganguli M, Mulsant B, Richards S, Stoehr G, Mendelsohn A. 1997. Antidepressant use over time in a rural older adult population: The MoVIES Project. J Am Geriatr Soc 45:1501-1303.
9. Henry JA, Rivas CA. 1997. Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment. Pharmacoeconomics 11:419-443.
10. Johnson RE, McFarland BH, Nichols GA. 1997. Changing patterns of antidepressant use and costs in a health maintenance organization. Pharmacoeconomics 11:274-286.
11. Keck PE, McElroy SL. 1997. New uses for antidepressants: Social phobia. J Clin Psychiatry 58:32-38.
12. Loosbrock DL, Tomlin ME, Robinson RL, Obenchain RL, Croghan TW. 2002. Appropriateness of prescribing practices for serotonergic antidepressants. Psychiatr Serv 53:179-184.
13. López-Ibor JJ, Alamo C, López-Muñoz F, Cuenca E, Rubio G, Otero FJ. 1999. A comparative analysis of depression management in primary care practice in Spain: 1997 versus 1982. Prim Care Psychiatry 5:133-145.
14. López-Ibor JJ, Alamo C, López Muñoz F, Cuenca E, Rubio G, Otero FJ. 2000. Evolution of the management of depression in Spain from the psychiatrist's perspective. A comparative analysis: 1997 versus 1982. Eur Psychiatr 15:362-369.
15. López-Muñoz F, Alamo C, Cuenca E. 1998a. Fármacos antidepresivos. In: López-Muñoz F, Alamo C, editors. Historia de la Neuropsicofarmacología. Madrid: Ediciones Eurobook, S.L., and Servicio de Publicaciones de la Universidad de Alcalá. p. 269-303.
16. López-Muñoz F, Echániz T, Sanz-Galeote J, Rubio G, Alamo C. 1998b. Pharmacoeconomic considerations of selective serotonin reuptake inhibitors (SSRIS) within the European Union. J Med Economics 1:177-187.
17. López-Piñero JM, Terrada ML. 1992. Los indicadores bibliométricos y la evaluación de la actividad médico-científica. IV. La aplicación de los indicadores. Med Clin (Barc) 98:384-388.
18. Lotka AJ. 1926. The frecuency distribution of scientific productivity. J Wash Acad Sci 16:317-323.
19. Muller HJ, Volz HP. 1996. Drug treatment of depression in the 1990s: An overview of achievements and future possibilities. Drugs 52:625-638.
20. Price DJS. 1963. Little science, big science. New York: Columbia University Press.
21. Sheehan DV, Harnett-Sheehan K. 1996. The role of SSRIs in panic disorder. J Clin Psychiatry 57:51-75.
22. Skaer TL, Selar DA, Robison LM, Galin RS. 2000. Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US. An assessment of office-based visit 1990 to 1998. CNS Drugs 14:473-481.
23. Vallejo J. 1996. Antidepresivos en los trastornos obsesivos. In: Vallejo J, Gastó C, editors. Antidepresivos en la Clínica Psiquiátrica. Madrid: Mosby/Doyma Libros, S.A. p 55-68.